Morgan Stanley’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1
Closed -$1 8008
2023
Q3
$1 Sell
1
-740
-100% -$740 ﹤0.01% 7606
2023
Q2
$685 Sell
741
-1,581
-68% -$1.46K ﹤0.01% 7344
2023
Q1
$1.76K Buy
2,322
+134
+6% +$102 ﹤0.01% 7264
2022
Q4
$5.49K Buy
2,188
+14
+0.6% +$35 ﹤0.01% 7123
2022
Q3
$3K Sell
2,174
-1
-0% -$1 ﹤0.01% 7421
2022
Q2
$3K Buy
2,175
+2,167
+27,088% +$2.99K ﹤0.01% 7546
2022
Q1
$0 Buy
8
+7
+700% ﹤0.01% 8222
2021
Q4
$0 Hold
1
﹤0.01% 8198
2021
Q3
$0 Buy
+1
New ﹤0.01% 8080
2020
Q3
Sell
-3,857
Closed -$13K 6868
2020
Q2
$13K Buy
3,857
+1,271
+49% +$4.28K ﹤0.01% 6108
2020
Q1
$5K Sell
2,586
-4,151
-62% -$8.03K ﹤0.01% 6234
2019
Q4
$27K Buy
6,737
+255
+4% +$1.02K ﹤0.01% 6033
2019
Q3
$21K Buy
6,482
+3,499
+117% +$11.3K ﹤0.01% 6001
2019
Q2
$12K Sell
2,983
-2,642
-47% -$10.6K ﹤0.01% 6088
2019
Q1
$137K Buy
5,625
+2,996
+114% +$73K ﹤0.01% 5246
2018
Q4
$53K Sell
2,629
-578
-18% -$11.7K ﹤0.01% 5749
2018
Q3
$98K Buy
3,207
+3,191
+19,944% +$97.5K ﹤0.01% 5697
2018
Q2
$0 Buy
16
+13
+433% ﹤0.01% 6787
2018
Q1
$0 Sell
3
-2
-40% ﹤0.01% 6738
2017
Q4
$0 Sell
5
-34
-87% ﹤0.01% 6695
2017
Q3
$1K Sell
39
-116
-75% -$2.97K ﹤0.01% 6482
2017
Q2
$1K Hold
155
﹤0.01% 6538
2017
Q1
$1K Sell
155
-3,497
-96% -$22.6K ﹤0.01% 6521
2016
Q4
$35K Buy
3,652
+3,602
+7,204% +$34.5K ﹤0.01% 5846
2016
Q3
$2K Buy
50
+3
+6% +$120 ﹤0.01% 6381
2016
Q2
$2K Sell
47
-1
-2% -$43 ﹤0.01% 6378
2016
Q1
$1K Sell
48
-38
-44% -$792 ﹤0.01% 6495
2015
Q4
$2K Buy
86
+38
+79% +$884 ﹤0.01% 6518
2015
Q3
$2K Hold
48
﹤0.01% 6497
2015
Q2
$2K Hold
48
﹤0.01% 6522
2015
Q1
$2K Hold
48
﹤0.01% 6440
2014
Q4
$3K Hold
48
﹤0.01% 6406
2014
Q3
$4K Hold
48
﹤0.01% 6370
2014
Q2
$7K Sell
48
-595
-93% -$86.8K ﹤0.01% 6253
2014
Q1
$100K Buy
643
+596
+1,268% +$92.7K ﹤0.01% 5446
2013
Q4
$7K Buy
+47
New +$7K ﹤0.01% 6111